Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?
- 1 September 2017
- journal article
- review article
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 98 (9) , 609-617
Abstract
No abstract availableKeywords
Funding Information
- NIH Cancer Center Support Grant (P30 CA008748)
This publication has 97 references indexed in Scilit:
- Immunologic Response to Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2012
- Percutaneous image‐guided cryoablation of painful metastases involving boneCancer, 2012
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- Percutaneous Cryoablation for the Treatment of Medically Inoperable Stage I Non-Small Cell Lung CancerPLOS ONE, 2012
- Irreversible electroporation on the small intestineBritish Journal of Cancer, 2012
- Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat StudyJournal of Thoracic Oncology, 2011
- The Effects of Irreversible Electroporation (IRE) on NervesPLOS ONE, 2011
- Quality Improvement Guidelines for Bone Tumour ManagementCardioVascular and Interventional Radiology, 2010
- Cryoablation or radiofrequency ablation of the small renal massCancer, 2008
- Predictors of Quality of Life in Oncology Outpatients with Pain from Bone MetastasisJournal of Pain and Symptom Management, 2005